Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Optical Coherence Tomography in Discrimination Between the Presence and Absence of Invasion in Clinical Actinic Keratosis

NCT06014697 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT06014697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06014697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Optical Coherence Tomography in Discrimination Between the Presence and Absence of Invasion in Clinical Actinic Keratosis
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
March 1, 2023
Completion date
August 1, 2024
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses, bowen's disease, cutaneous squamous cell carcinoma, diagnosis, keratosis, actinic